Calvary Scenario

Calviri is a clinical-stage biotechnology company focused on the development of preventative and therapeutic cancer vaccines and early-detection diagnostics. Spun out from Arizona State University's Biodesign Institute, the company utilizes its proprietary Immunosignaturing and Frameshift peptide platforms to identify unique neoantigens common across different cancer types. Their lead programs include a preventative cancer vaccine for dogs and a therapeutic vaccine for human solid tumors. Calviri aims to revolutionize oncology by providing off-the-shelf vaccines that can prevent cancer before it starts or treat it in its earliest stages.